US Stock MarketDetailed Quotes

DRMA Dermata Therapeutics

Watchlist
  • 0.3360
  • -0.0041-1.21%
Close May 3 16:00 ET
  • 0.3418
  • +0.0058+1.73%
Post 19:40 ET
2.24MMarket Cap-125P/E (TTM)

Dermata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
19.18%7.44M
19.18%7.44M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
-42.20%6.24M
-35.99%8.07M
2,387.79%10.63M
515.67%8.19M
-Cash and cash equivalents
19.18%7.44M
19.18%7.44M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
-42.20%6.24M
-35.99%8.07M
2,387.79%10.63M
515.67%8.19M
Receivables
-33.69%8.36K
-33.69%8.36K
-99.41%76
--790
--6.36K
--12.6K
--12.6K
--12.89K
----
----
-Accrued interest receivable
-33.69%8.36K
-33.69%8.36K
-99.41%76
--790
--6.36K
--12.6K
--12.6K
--12.89K
----
----
Prepaid assets
-22.94%532.14K
-22.94%532.14K
-22.72%691.82K
-31.36%273.56K
-22.49%521.99K
-10.24%690.59K
-10.24%690.59K
-17.30%895.17K
1,684.47%398.54K
1,477.39%673.47K
Current deferred assets
----
----
----
----
----
----
----
--0
--0
-32.32%179.59K
Total current assets
14.89%7.98M
14.89%7.98M
-18.40%7.32M
-20.98%8.71M
2.78%9.3M
-40.26%6.94M
-40.26%6.94M
-34.42%8.97M
869.90%11.03M
447.73%9.04M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
14.89%7.98M
14.89%7.98M
-18.40%7.32M
-20.98%8.71M
2.78%9.3M
-40.26%6.94M
-40.26%6.94M
-34.42%8.97M
869.90%11.03M
447.73%9.04M
Liabilities
Current liabilities
Payables
74.36%866.03K
74.36%866.03K
-1.92%474.46K
-28.09%437.78K
-25.57%492.87K
-3.60%496.7K
-3.60%496.7K
-37.17%483.74K
-30.92%608.81K
35.68%662.23K
-accounts payable
74.36%866.03K
74.36%866.03K
-1.92%474.46K
-28.09%437.78K
-25.57%492.87K
-3.60%496.7K
-3.60%496.7K
-37.17%483.74K
-30.92%608.81K
35.68%662.23K
Current accrued expenses
-83.92%41.1K
-83.92%41.1K
-82.51%113.31K
-86.28%63.12K
83.09%582.91K
8.56%255.54K
8.56%255.54K
80,883.38%647.87K
-21.59%459.89K
15.22%318.37K
Current liabilities
75.98%1.62M
75.98%1.62M
-39.05%916.82K
-50.03%682.86K
1.30%1.21M
-39.17%922.63K
-39.17%922.63K
25.86%1.5M
-16.81%1.37M
26.87%1.19M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
75.98%1.62M
75.98%1.62M
-39.05%916.82K
-50.03%682.86K
1.30%1.21M
-39.17%922.63K
-39.17%922.63K
25.86%1.5M
-16.81%1.37M
26.87%1.19M
Shareholders'equity
Share capital
410.39%393
410.39%393
-73.64%319
-68.42%319
-71.31%239
-90.76%77
-90.76%77
45.26%1.21K
-86.42%1.01K
-88.80%833
-common stock
410.39%393
410.39%393
-73.64%319
-68.42%319
-71.31%239
-90.76%77
-90.76%77
45.26%1.21K
428.80%1.01K
336.13%833
Retained earnings
-17.10%-53.39M
-17.10%-53.39M
-16.69%-51.25M
-19.36%-49.53M
-23.38%-47.83M
-26.71%-45.59M
-26.71%-45.59M
-31.39%-43.92M
-30.84%-41.5M
-27.59%-38.77M
Paid-in capital
15.75%59.74M
15.75%59.74M
12.19%57.66M
12.52%57.56M
19.95%55.92M
11.99%51.61M
11.99%51.61M
11.92%51.39M
63.95%51.16M
49.96%46.62M
Total stockholders'equity
5.53%6.36M
5.53%6.36M
-14.24%6.41M
-16.87%8.03M
3.00%8.09M
-40.42%6.02M
-40.42%6.02M
-83.73%7.47M
2,009.83%9.66M
1,002.88%7.85M
Total equity
5.53%6.36M
5.53%6.36M
-14.24%6.41M
-16.87%8.03M
3.00%8.09M
-40.42%6.02M
-40.42%6.02M
-40.19%7.47M
2,009.83%9.66M
1,002.88%7.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 19.18%7.44M19.18%7.44M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M-42.20%6.24M-35.99%8.07M2,387.79%10.63M515.67%8.19M
-Cash and cash equivalents 19.18%7.44M19.18%7.44M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M-42.20%6.24M-35.99%8.07M2,387.79%10.63M515.67%8.19M
Receivables -33.69%8.36K-33.69%8.36K-99.41%76--790--6.36K--12.6K--12.6K--12.89K--------
-Accrued interest receivable -33.69%8.36K-33.69%8.36K-99.41%76--790--6.36K--12.6K--12.6K--12.89K--------
Prepaid assets -22.94%532.14K-22.94%532.14K-22.72%691.82K-31.36%273.56K-22.49%521.99K-10.24%690.59K-10.24%690.59K-17.30%895.17K1,684.47%398.54K1,477.39%673.47K
Current deferred assets ------------------------------0--0-32.32%179.59K
Total current assets 14.89%7.98M14.89%7.98M-18.40%7.32M-20.98%8.71M2.78%9.3M-40.26%6.94M-40.26%6.94M-34.42%8.97M869.90%11.03M447.73%9.04M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets 14.89%7.98M14.89%7.98M-18.40%7.32M-20.98%8.71M2.78%9.3M-40.26%6.94M-40.26%6.94M-34.42%8.97M869.90%11.03M447.73%9.04M
Liabilities
Current liabilities
Payables 74.36%866.03K74.36%866.03K-1.92%474.46K-28.09%437.78K-25.57%492.87K-3.60%496.7K-3.60%496.7K-37.17%483.74K-30.92%608.81K35.68%662.23K
-accounts payable 74.36%866.03K74.36%866.03K-1.92%474.46K-28.09%437.78K-25.57%492.87K-3.60%496.7K-3.60%496.7K-37.17%483.74K-30.92%608.81K35.68%662.23K
Current accrued expenses -83.92%41.1K-83.92%41.1K-82.51%113.31K-86.28%63.12K83.09%582.91K8.56%255.54K8.56%255.54K80,883.38%647.87K-21.59%459.89K15.22%318.37K
Current liabilities 75.98%1.62M75.98%1.62M-39.05%916.82K-50.03%682.86K1.30%1.21M-39.17%922.63K-39.17%922.63K25.86%1.5M-16.81%1.37M26.87%1.19M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 75.98%1.62M75.98%1.62M-39.05%916.82K-50.03%682.86K1.30%1.21M-39.17%922.63K-39.17%922.63K25.86%1.5M-16.81%1.37M26.87%1.19M
Shareholders'equity
Share capital 410.39%393410.39%393-73.64%319-68.42%319-71.31%239-90.76%77-90.76%7745.26%1.21K-86.42%1.01K-88.80%833
-common stock 410.39%393410.39%393-73.64%319-68.42%319-71.31%239-90.76%77-90.76%7745.26%1.21K428.80%1.01K336.13%833
Retained earnings -17.10%-53.39M-17.10%-53.39M-16.69%-51.25M-19.36%-49.53M-23.38%-47.83M-26.71%-45.59M-26.71%-45.59M-31.39%-43.92M-30.84%-41.5M-27.59%-38.77M
Paid-in capital 15.75%59.74M15.75%59.74M12.19%57.66M12.52%57.56M19.95%55.92M11.99%51.61M11.99%51.61M11.92%51.39M63.95%51.16M49.96%46.62M
Total stockholders'equity 5.53%6.36M5.53%6.36M-14.24%6.41M-16.87%8.03M3.00%8.09M-40.42%6.02M-40.42%6.02M-83.73%7.47M2,009.83%9.66M1,002.88%7.85M
Total equity 5.53%6.36M5.53%6.36M-14.24%6.41M-16.87%8.03M3.00%8.09M-40.42%6.02M-40.42%6.02M-40.19%7.47M2,009.83%9.66M1,002.88%7.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg